Figure 4

Forest plots of OS in NSCLC patients treated with platinum-based chemotherapy by the GSTM1 null or present polymorphism (null vs. present). Hazard ratios (HRs) (and its 95% confidence interval (CI)) of overall survival (OS) stratified by ethnicity for the GSTM1 null or present polymorphism null vs. present.